https://insights.citeline.com/medtech-insight/business/strategy/noctrixs-nidra-breaks-through-wearable-noise-to-win-coverage-for-restless-leg-syndrome-treatment-LOJ75OFRLBBT7O67DGUG42KY6Y/2026-04-07T22:57:08.403Zalways0.5Insightsen2026-04-07T22:57:08.403Zhttps://insights.citeline.com/resizer/31DE_mkd07kmcpCSryGpnYHlySk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/OSCSXP57AVDRTKCWB463XRSMCA.jpghttps://insights.citeline.com/pink-sheet/compliance/tidmarsh-gone-but-us-fda-still-targets-animal-derived-thyroid-medication-TQDH6AU6H5A5BG6NM6W5K44ZFY/2026-04-07T22:32:54.375Zalways0.5Insightsen2026-04-07T22:32:54.375Zhttps://insights.citeline.com/resizer/xLJdqxjCQjfIGaHmtzQ-b90o5AA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/SKOQNB2ZA5DM3AFGMSJFX2A72I.jpghttps://insights.citeline.com/pink-sheet/agency-leadership/ema/ema-looks-to-virtual-control-groups-to-reduce-animal-testing-in-drug-development-5ZL3ROBCV5BONIKNINCTLQCQ7Q/2026-04-07T22:32:16.578Zalways0.5Insightsen2026-04-07T22:32:16.578Zhttps://insights.citeline.com/resizer/hUg7DzpCM0l_aBhynOgPuWWDA_g=/cloudfront-us-east-1.images.arcpublishing.com/norstella/5WUDKKI2HFC6TFWCCE5CSJDV4Y.jpghttps://insights.citeline.com/pink-sheet/product-reviews/approvals/grifols-fesilty-review-shows-us-fda-still-can-deliver-timely-approvals-HYIINPIQPJFKVCKI6J5JVMRLGU/2026-04-07T22:31:58.655Zalways0.5Insightsen2026-04-07T22:31:58.655Zhttps://insights.citeline.com/resizer/bm7ZrPHHPfOmlTWep0HVtmOuA-o=/cloudfront-us-east-1.images.arcpublishing.com/norstella/WWG6P74Y2VF2VKUNNP776CVDGU.jpghttps://insights.citeline.com/pink-sheet/legislation/eu-pharma-legislation-reform/a-fundamental-shift-what-the-eu-pharma-reform-means-for-orphan-drugs-UXUGRHJYEZAWBCXD7JP3UOOAAM/2026-04-07T22:31:28.673Zalways0.5Insightsen2026-04-07T22:31:28.673Zhttps://insights.citeline.com/resizer/sHQD95q19z5x4ejKFNwITHzsEaE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BK3LPLSBQNHPLFQRDCNA3VOXMA.jpghttps://insights.citeline.com/pink-sheet/pathways-and-standards/user-fees/pdufa-viii-us-anchored-phase-i-clinical-studies-could-mean-millions-in-fee-discounts-YQEFDDR73VBM3D7KFR5LDUUH3U/2026-04-07T22:31:15.606Zalways0.5Insightsen2026-04-07T22:31:15.606Zhttps://insights.citeline.com/resizer/35gu0Rvzgg1Q4uZ2-NhYPUV4zgQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/LKUU6MOC2NGPFCUVUXXQFSX5JU.jpghttps://insights.citeline.com/hbw-insight/beauty/policy-and-regulation/eu-beauty-industry-targets-misinformation-on-chemicals-omnibus-OYZDZQA3BBFYBNJYIVIEBCGF4M/2026-04-07T22:21:10.151Zalways0.5Insightsen2026-04-07T22:21:10.151Zhttps://insights.citeline.com/resizer/ulP_0gJ6bngpYmXTfXfxWIzfTLY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/GTFHML7LH5PXPH73Z6K57LYEGM.jpghttps://insights.citeline.com/medtech-insight/device-area/luminopias-digital-therapeutic-shows-early-promise-for-intermittent-exotropia-in-small-pilot-study-RPQ5NZK2LNH2HPXAHHPQA335H4/2026-04-07T21:10:52.077Zalways0.5Insightsen2026-04-07T21:10:52.077Zhttps://insights.citeline.com/resizer/RaaU0nCpuQD0sYtETZq_T5-Oza0=/cloudfront-us-east-1.images.arcpublishing.com/norstella/TJEI4RBFCFCURLRQLZPGX6SVNE.jpghttps://insights.citeline.com/hbw-insight/health/business/deals/prestige-consumer-healthcare-takes-deep-international-breath-with-breathe-right-deal-X25QQC4DDZBCDFI2WFEI4UW7BQ/2026-04-07T18:25:59.868Zalways0.5Insightsen2026-04-07T18:25:59.868Zhttps://insights.citeline.com/resizer/mndEpImpHSOZCwhJ-A3E9bNemU4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/YIOK2EZT5FESLI45P72HPRGL5M.jpghttps://insights.citeline.com/hbw-insight/health/rx-to-otc-switch/japan-firms-can-trigger-otc-reclassification-process-under-new-scheme-MLRJXXFMWJH2ZCNJWJNYCOK7FY/2026-04-07T15:55:28.749Zalways0.5Insightsen2026-04-07T15:55:28.749Zhttps://insights.citeline.com/resizer/3feB_ZMZ7iANxzW4BnHtLx-kZ3Q=/cloudfront-us-east-1.images.arcpublishing.com/norstella/Q7O4KXCDO5HPPKUPRHCWFJJDY4.jpghttps://insights.citeline.com/in-vivo/market-intelligence/biobytes/evogene-bets-on-autonomous-small-molecule-discovery-TG4D7RXWVJDIXKIFZIXKL63PBE/2026-04-07T15:53:37.018Zalways0.5Insightsen2026-04-07T15:53:37.018Zhttps://insights.citeline.com/resizer/mx6eMXr3O2IBX962vv1M11FoOiA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/6W6F3UFFLNODHAOFO75FTNCPEE.jpghttps://insights.citeline.com/hbw-insight/wellness/business/earnings/venture-life-growing-hormonal-health-offering-in-us-and-uk-ERURGBSIMFBLFJ5UWCF3DESAHY/2026-04-07T15:14:04.113Zalways0.5Insightsen2026-04-07T15:14:04.113Zhttps://insights.citeline.com/resizer/Do0C95i5OGVMFlT545Tw1qag3iE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/H77RUSKUOZAE7A2YU6QDU25GHQ.jpghttps://insights.citeline.com/generics-bulletin/products/biosimilars/phase-iii-success-puts-aurobindo-in-xolair-biosimilars-race-4VN2FUZSSJGEBFTDLALHV6WHR4/2026-04-07T14:43:31.928Zalways0.5Insightsen2026-04-07T14:43:31.928Zhttps://insights.citeline.com/resizer/M6wdnUlj_wxdF8MpjNcLzm_utSs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JE3QQG24JFDD7ELOHHSHUXAHYA.jpghttps://insights.citeline.com/medtech-insight/are-ai-device-regulations-forgetting-the-human-factor-BPDJEFETTJERNKURXV37DQ637A/2026-04-07T13:24:28.927Zalways0.5Insightsen2026-04-07T13:24:28.927Zhttps://insights.citeline.com/resizer/orE_eWr_kI0Fd6QoVzL_Xewgu0E=/cloudfront-us-east-1.images.arcpublishing.com/norstella/WH3XBFTS2BFBBHGTAWRJTFYOYU.jpghttps://insights.citeline.com/medtech-insight/algorithm-outperforms-human-glucose-monitoring-in-t2d-study-Q4USAUW2ZVDCJKQOEVYCCJUBDA/2026-04-07T13:24:27.024Zalways0.5Insightsen2026-04-07T13:24:27.024Zhttps://insights.citeline.com/resizer/hjcBILT7NicobNuck-RImNUgn-Y=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HGJOVZCPV5JDZOD6MYJYK4LOTI.jpghttps://insights.citeline.com/medtech-insight/medtech-europe-calls-for-coordinated-wound-care-policy-37UYXXS3PRDW3GK35DHEWIW3D4/2026-04-07T13:24:26.657Zalways0.5Insightsen2026-04-07T13:24:26.657Zhttps://insights.citeline.com/resizer/IdKuLtSvpvtsaMkSD0G3F6buDHM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ZHY4CELCBRIOXFWLPJCQZO7O2U.jpghttps://insights.citeline.com/generics-bulletin/business/deals/hikma-and-glenmarks-ryaltris-break-up-illustrates-shifts-in-strategies-U5Z6N5AOSRFP3PDEVHNHGYHLIM/2026-04-07T13:08:28.979Zalways0.5Insightsen2026-04-07T13:08:28.979Zhttps://insights.citeline.com/resizer/vs08szDsWjbJU705giDJbZIN9XI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/AJ4T27RW6NFVFOJROBFROEXSZI.jpghttps://insights.citeline.com/scrip/market-intelligence/company-rankings/scrip-100-double-digit-growth-propels-leaderboard-gainers-F6OM2LSVNJH7TASI6GFC3DOBIU/2026-04-07T12:30:11.708Zalways0.5Insightsen2026-04-07T12:30:11.708Zhttps://insights.citeline.com/resizer/aFMs3spZv6AoOjAmhiX3CGPAm28=/cloudfront-us-east-1.images.arcpublishing.com/norstella/KAXDKKRXFBD5HFCRP6MLV7RH2M.jpghttps://insights.citeline.com/scrip/business/deals/top-five-deals-of-2025-soar-past-2024-valuations-DWZMJWCDERCY7HRTC5CUFBO7KQ/2026-04-07T12:23:05.687Zalways0.5Insightsen2026-04-07T12:23:05.687Zhttps://insights.citeline.com/resizer/CMZu7PqUpzrJc8u37mYoTVlM3Cc=/cloudfront-us-east-1.images.arcpublishing.com/norstella/I7FXKQ5AKBL4JJK2BTAKDBHSQE.jpghttps://insights.citeline.com/pink-sheet/regional-comparisons/india-weighs-public-disclosure-of-risk-based-inspections-X3VQEBU7MZEJLIF4TKGK65QX4Q/2026-04-07T11:23:39.921Zalways0.5Insightsen2026-04-07T11:23:39.921Zhttps://insights.citeline.com/resizer/Ym-G4Y17kdZbOmOHsRo_Y3Z3Bzw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/6GJUWRXTO5DM3AKJE6PC2CZ7II.jpghttps://insights.citeline.com/generics-bulletin/business/deals/tacrolimus-acquisition-highlights-cnx-strategy-in-niche-generics-Y3X57BFEW5FQJJNNULFS3XA5MQ/2026-04-07T10:31:10.997Zalways0.5Insightsen2026-04-07T10:31:10.997Zhttps://insights.citeline.com/resizer/veDPtM3i8rAAtOLBMXPMW3Fvymg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ZCLHGP7X5BJV7HZEC4ED4UIA2Q.jpghttps://insights.citeline.com/generics-bulletin/business/deals/visufarma-gives-lupin-platform-for-global-ophthalmology-push-S6R2LJYFNNB6TFOPVWSKKYXAPI/2026-04-07T10:31:07.664Zalways0.5Insightsen2026-04-07T10:31:07.664Zhttps://insights.citeline.com/resizer/AIviGC7eXnXF8foOj0e04m6ZAHk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/J6HIJ445ARDWPIWM7VEZHTK72U.jpghttps://insights.citeline.com/in-vivo/podcasts/podcast-inside-step-pharmas-pancancer-ambition-ABJHNDT7BVATJGPKUZXS57SLTA/2026-04-07T08:59:32.807Zalways0.5Insightsen2026-04-07T08:59:32.807Zhttps://insights.citeline.com/resizer/ZRS16ILQ0j4uuhBNksV741SfUWI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/I775OILYCVCTFNEIV7IFDNKQQI.pnghttps://insights.citeline.com/scrip/business/top-selling-drugs-2024-keytruda-ozempic-and-dupixent-dominate-K6SLDZMQEFFYJDRJNXV6T4RLBY/2026-04-07T08:45:22.267Zalways0.5Insightsen2026-04-07T08:45:22.267Zhttps://insights.citeline.com/resizer/QO3HZAvnLazON5RtYErXgPqNbDI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/3KOK6FC3BFHGBHFKTZ2WEMQXZM.jpghttps://insights.citeline.com/scrip/business/earnings/top-10-drugs-q3-2025-obesity-gold-rush-helps-add-10bn-to-revenues-N3H4RZNFXNC6BEUNWI45XJJ27Q/2026-04-07T08:45:17.457Zalways0.5Insightsen2026-04-07T08:45:17.457Zhttps://insights.citeline.com/resizer/UIfdrhgOW25pLS_XamGYYH5T6jw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/6U5JVZ4E2VA6TLBCUOKGECZAPM.jpghttps://insights.citeline.com/scrip/business/earnings/top-10-drugs-q3-2024-paxlovid-returns-as-humira-bows-out-RZWZ2NJLJZDEBEMLQKK74QZP3E/2026-04-07T08:44:50.82Zalways0.5Insightsen2026-04-07T08:44:50.82Zhttps://insights.citeline.com/resizer/044E8WDKHihT_qg24sUF9no2b7Y=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HCOGO4KETBD3DJQWBXUMSIYWA4.jpghttps://insights.citeline.com/scrip/business/earnings/top-10-drugs-q1-2025-keytruda-dominates-mounjaro-climbs-W3KWB7Y3DNBM7NDWJLCCSOZMTQ/2026-04-07T08:44:05.92Zalways0.5Insightsen2026-04-07T08:44:05.92Zhttps://insights.citeline.com/resizer/0rQTSUEIY384UZZZGxTQgK9l4rA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/VCT4LIJZWJGGXIRDNNPY35LSSM.jpghttps://insights.citeline.com/scrip/business/earnings/top-10-drugs-q2-2024-mounjaro-comes-roaring-in-BNDTGDXGYVHLTDTAFI5I5PRYZQ/2026-04-07T08:41:13.252Zalways0.5Insightsen2026-04-07T08:41:13.252Zhttps://insights.citeline.com/resizer/GXv54LITbU0-Rni1kZID-QMg1FM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/DR77Y2P5UFFQ3FVV6XX3FGP5ZU.jpghttps://insights.citeline.com/medtech-insight/geography/europe/united-kingdom/mhra-wants-to-keep-us-fda-close-and-eu-closer-BBFLNGZZSJF5HAUR6TACX62G44/2026-04-07T08:07:45.036Zalways0.5Insightsen2026-04-07T08:07:45.036Zhttps://insights.citeline.com/resizer/VpGO0QHImeJJFT9694IRApq5ZI8=/cloudfront-us-east-1.images.arcpublishing.com/norstella/2PCRXCXF4JGQTOCCO7SQCUUJKU.jpghttps://insights.citeline.com/in-vivo/leadership/execs-on-the-move-november-2025-XFLVE55V4JC5VD3Z6VIPTVQ6DM/2026-04-07T08:06:25.951Zalways0.5Insightsen2026-04-07T08:06:25.951Zhttps://insights.citeline.com/resizer/h4fVGgwOIyO4RzeYcyFoc_E91Qo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QSTAM7SGMJOYTGEBU2RZSDKLYA.jpghttps://insights.citeline.com/in-vivo/leadership/execs-on-the-move-september-2025-27TCDWQTNRDJ5NUQT6JGG4VIZE/2026-04-07T08:06:24.067Zalways0.5Insightsen2026-04-07T08:06:24.067Zhttps://insights.citeline.com/resizer/h4fVGgwOIyO4RzeYcyFoc_E91Qo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QSTAM7SGMJOYTGEBU2RZSDKLYA.jpghttps://insights.citeline.com/in-vivo/leadership/execs-on-the-move-july-2025-URK46B3QIRASXHXT2QZD4RTLOA/2026-04-07T08:05:59.464Zalways0.5Insightsen2026-04-07T08:05:59.464Zhttps://insights.citeline.com/resizer/h4fVGgwOIyO4RzeYcyFoc_E91Qo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QSTAM7SGMJOYTGEBU2RZSDKLYA.jpghttps://insights.citeline.com/in-vivo/leadership/execs-on-the-move-january-2026-UXDYULDT4RA3FO5LGROYQ2TJFA/2026-04-07T08:05:39.039Zalways0.5Insightsen2026-04-07T08:05:39.039Zhttps://insights.citeline.com/resizer/h4fVGgwOIyO4RzeYcyFoc_E91Qo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QSTAM7SGMJOYTGEBU2RZSDKLYA.jpghttps://insights.citeline.com/in-vivo/leadership/execs-on-the-move-april-2025-LXNPOBU7HBDWZKVRLKHKNETLQY/2026-04-07T08:05:37.874Zalways0.5Insightsen2026-04-07T08:05:37.874Zhttps://insights.citeline.com/resizer/h4fVGgwOIyO4RzeYcyFoc_E91Qo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QSTAM7SGMJOYTGEBU2RZSDKLYA.jpghttps://insights.citeline.com/in-vivo/leadership/execs-on-the-move-january-2025-QMOZKNF24FG5ZFEPYSY6ZOS7VU/2026-04-07T08:05:29.731Zalways0.5Insightsen2026-04-07T08:05:29.731Zhttps://insights.citeline.com/resizer/h4fVGgwOIyO4RzeYcyFoc_E91Qo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QSTAM7SGMJOYTGEBU2RZSDKLYA.jpghttps://insights.citeline.com/in-vivo/leadership/execs-on-the-move-december-2024-SKQC4YCGEJHIXP7FQJJ7HQMTTM/2026-04-07T08:05:22.837Zalways0.5Insightsen2026-04-07T08:05:22.837Zhttps://insights.citeline.com/resizer/h4fVGgwOIyO4RzeYcyFoc_E91Qo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QSTAM7SGMJOYTGEBU2RZSDKLYA.jpghttps://insights.citeline.com/in-vivo/leadership/execs-on-the-move-november-2024-XBP5NCM72VGUHBXAYNU6B2EO6Q/2026-04-07T08:05:19.062Zalways0.5Insightsen2026-04-07T08:05:19.062Zhttps://insights.citeline.com/resizer/h4fVGgwOIyO4RzeYcyFoc_E91Qo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QSTAM7SGMJOYTGEBU2RZSDKLYA.jpghttps://insights.citeline.com/in-vivo/leadership/execs-on-the-move-october-2024-EP2OKIFHCFF5TGAFRVGWWRBRYE/2026-04-07T08:05:13.512Zalways0.5Insightsen2026-04-07T08:05:13.512Zhttps://insights.citeline.com/resizer/h4fVGgwOIyO4RzeYcyFoc_E91Qo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QSTAM7SGMJOYTGEBU2RZSDKLYA.jpghttps://insights.citeline.com/IV154616/Execs-On-The-Move-April-2024/2026-04-07T08:04:49.984Zalways0.5Insightsen2026-04-07T08:04:49.984Zhttps://insights.citeline.com/resizer/e_jae57af0LyFDZoiEp9yauya-I=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HSKZVVRBORIXPNSLUKYPDLMYCI.jpghttps://insights.citeline.com/IV154602/Execs-On-The-Move-March-2024/2026-04-07T08:04:23.941Zalways0.5Insightsen2026-04-07T08:04:23.941Zhttps://insights.citeline.com/resizer/qdD5Q_QJgTeSC7E2Ktx9s9_q4WI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/Y73BS2LH65K7NOAEKGOUWBRAQA.jpghttps://insights.citeline.com/pink-sheet/geography/asia/japan/iran-war-japan-braces-for-potential-impact-on-drug-medical-supplies-2JSUXTY3GNH2LLQOTEQAOVIDQI/2026-04-07T07:39:33.132Zalways0.5Insightsen2026-04-07T07:39:33.132Zhttps://insights.citeline.com/resizer/rdNv9Gknf_dIlgaXEhSG7wV9XIk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ODCS7TQS7BD77OBX4HWZVG547Y.jpghttps://insights.citeline.com/in-vivo/brain-computer-interfaces-outrun-insurance-K33S3T65AZADVE7REFL3IT5OT4/2026-04-07T06:43:28.377Zalways0.5Insightsen2026-04-07T06:43:28.377Zhttps://insights.citeline.com/resizer/YpP7dEU1-oLLisr_5Nm0K4Y6Lbk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/4XKXCONLFRFURDGH62Z5RGVSZ4.jpghttps://insights.citeline.com/hbw-insight/health/business/manufacturing/ema-explains-how-to-use-emerging-3d-printing-technology-for-solid-oral-drugs-MUS43SCQDFGKJPL5TUS5HBBC2E/2026-04-07T04:06:41.342Zalways0.5Insightsen2026-04-07T04:06:41.342Zhttps://insights.citeline.com/resizer/AhEVDSNMWDbu1lGRy2zR7--XIro=/cloudfront-us-east-1.images.arcpublishing.com/norstella/NMW66Z3QQVAJZG5JCYM3QQWDVE.jpghttps://insights.citeline.com/hbw-insight/wellness/business/marketing-and-advertising/ingredient-amounts-ok-on-nad-supplement-label-in-advertising-not-so-much-IHCUDUJZYZHWTNNSQJ4XEJM3I4/2026-04-07T03:05:41.349Zalways0.5Insightsen2026-04-07T03:05:41.349Zhttps://insights.citeline.com/resizer/Z9VtUyrBLfCvN_ocRIOYy__SAeU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/TG7DYGAMTNFDNECRHNZVFZV36Y.jpghttps://insights.citeline.com/scrip/business/deals/neurocrine-takes-sensible-way-into-metabolic-disease-with-29bn-soleno-buy-FQXVQVK42JFFPPTAFOWUMUUF4I/2026-04-07T02:28:22.377Zalways0.5Insightsen2026-04-07T02:28:22.377Zhttps://insights.citeline.com/resizer/nh_on7YonoFG7JpVOaqM50mNx0E=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IHOPBJJEW5IRFP5CRAA2NYN73M.jpghttps://insights.citeline.com/scrip/business/deals/five-more-things-to-know-about-neurocrines-29bn-bid-for-soleno-E7IKKQ2I7JH3XKPFEVKLKFTZDY/2026-04-07T02:23:26.677Zalways0.5Insightsen2026-04-07T02:23:26.677Zhttps://insights.citeline.com/resizer/6d3nKSaUpyMymFvDFJrUpuLn1k4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/APCQNKIM7ZARHNGEM6TVLGPOV4.jpghttps://insights.citeline.com/hbw-insight/beauty/policy-and-regulation/europes-beauty-leaders-sound-alarm-in-brussels-over-regulatory-roadblocks-to-innovation-PYKXGMAAUZHXHJV7R2OE7KMPGA/2026-04-07T01:55:23.764Zalways0.5Insightsen2026-04-07T01:55:23.764Zhttps://insights.citeline.com/resizer/uRhHObWvKBgk3pq13VobKMoA2vE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BCG6AJXMW5PBLMXV7THUM5EZJE.jpghttps://insights.citeline.com/companies/westlake-university2026-04-07T00:07:10.386Zalways0.5Insightsen2026-04-07T00:07:10.386Zhttps://insights.citeline.com/companies/taiyo-holdings-co-ltd2026-04-07T00:06:56.345Zalways0.5Insightsen2026-04-07T00:06:56.345Zhttps://insights.citeline.com/companies/coval-biopharma-shanghai-co-ltd2026-04-07T00:06:46.141Zalways0.5Insightsen2026-04-07T00:06:46.141Zhttps://insights.citeline.com/companies/nanjing-huanbo-biotechnology-co-ltd2026-04-07T00:06:40.243Zalways0.5Insightsen2026-04-07T00:06:40.243Zhttps://insights.citeline.com/companies/noom-inc2026-04-07T00:06:34.013Zalways0.5Insightsen2026-04-07T00:06:34.013Zhttps://insights.citeline.com/companies/swiftpharma-bv2026-04-07T00:06:28.336Zalways0.5Insightsen2026-04-07T00:06:28.336Zhttps://insights.citeline.com/companies/shanghai-stairmed-technology-co-ltd2026-04-07T00:06:21.989Zalways0.5Insightsen2026-04-07T00:06:21.989Zhttps://insights.citeline.com/companies/cook-myosite2026-04-07T00:06:16.135Zalways0.5Insightsen2026-04-07T00:06:16.135Zhttps://insights.citeline.com/companies/alium-pharmaceutical-holding2026-04-07T00:06:09.984Zalways0.5Insightsen2026-04-07T00:06:09.984Zhttps://insights.citeline.com/companies/anlongbio-co-ltd2026-04-07T00:06:04.143Zalways0.5Insightsen2026-04-07T00:06:04.143Zhttps://insights.citeline.com/companies/inflamax-pharmaceutical2026-04-07T00:05:57.773Zalways0.5Insightsen2026-04-07T00:05:57.773Zhttps://insights.citeline.com/companies/fujian-haixi-pharmaceuticals-co-ltd2026-04-07T00:05:51.903Zalways0.5Insightsen2026-04-07T00:05:51.903Zhttps://insights.citeline.com/companies/kirin-holdings2026-04-07T00:05:45.917Zalways0.5Insightsen2026-04-07T00:05:45.917Zhttps://insights.citeline.com/companies/chengdu-fendi-pharmaceutical-co-ltd2026-04-07T00:05:39.936Zalways0.5Insightsen2026-04-07T00:05:39.936Zhttps://insights.citeline.com/companies/1cbio-inc2026-04-07T00:05:33.991Zalways0.5Insightsen2026-04-07T00:05:33.991Zhttps://insights.citeline.com/companies/axcynsis-therapeutics-pte-ltd2026-04-07T00:05:27.844Zalways0.5Insightsen2026-04-07T00:05:27.844Zhttps://insights.citeline.com/companies/image-guided-therapy-co-ltd2026-04-07T00:05:21.895Zalways0.5Insightsen2026-04-07T00:05:21.895Zhttps://insights.citeline.com/companies/wellington-zhaotai-therapies2026-04-07T00:05:15.803Zalways0.5Insightsen2026-04-07T00:05:15.803Zhttps://insights.citeline.com/companies/buzzard-pharmaceuticals-ab2026-04-07T00:05:09.689Zalways0.5Insightsen2026-04-07T00:05:09.689Zhttps://insights.citeline.com/companies/broken-string-biosciences-ltd2026-04-07T00:04:57.626Zalways0.5Insightsen2026-04-07T00:04:57.626Zhttps://insights.citeline.com/companies/alltrna2026-04-07T00:04:51.73Zalways0.5Insightsen2026-04-07T00:04:51.73Zhttps://insights.citeline.com/companies/frametact-limited2026-04-07T00:04:45.608Zalways0.5Insightsen2026-04-07T00:04:45.608Zhttps://insights.citeline.com/companies/fisher-paykel-healthcare-corp-ltd2026-04-07T00:04:33.446Zalways0.5Insightsen2026-04-07T00:04:33.446Zhttps://insights.citeline.com/companies/polyrizon-ltd2026-04-07T00:04:27.565Zalways0.5Insightsen2026-04-07T00:04:27.565Zhttps://insights.citeline.com/companies/uniquity-bio-inc2026-04-07T00:04:21.486Zalways0.5Insightsen2026-04-07T00:04:21.486Zhttps://insights.citeline.com/companies/atavistik-bio2026-04-07T00:04:15.274Zalways0.5Insightsen2026-04-07T00:04:15.274Zhttps://insights.citeline.com/companies/nanocopoeia-llc2026-04-07T00:04:03.476Zalways0.5Insightsen2026-04-07T00:04:03.476Zhttps://insights.citeline.com/companies/institut-pasteur2026-04-07T00:03:57.239Zalways0.5Insightsen2026-04-07T00:03:57.239Zhttps://insights.citeline.com/companies/mdimune-inc2026-04-07T00:03:51.213Zalways0.5Insightsen2026-04-07T00:03:51.213Zhttps://insights.citeline.com/companies/venus-concept-inc2026-04-07T00:03:38.888Zalways0.5Insightsen2026-04-07T00:03:38.888Zhttps://insights.citeline.com/companies/beijing-unistone-pharmaceutical-co-ltd2026-04-07T00:03:33.011Zalways0.5Insightsen2026-04-07T00:03:33.011Zhttps://insights.citeline.com/companies/advanced-oxygen-therapy-inc2026-04-07T00:03:26.929Zalways0.5Insightsen2026-04-07T00:03:26.929Zhttps://insights.citeline.com/companies/apellis-pharmaceuticals-inc2026-04-07T00:03:14.932Zalways0.5Insightsen2026-04-07T00:03:14.932Zhttps://insights.citeline.com/companies/akamis-bio2026-04-07T00:03:09.012Zalways0.5Insightsen2026-04-07T00:03:09.012Zhttps://insights.citeline.com/companies/nanovis-inc2026-04-07T00:03:03.041Zalways0.5Insightsen2026-04-07T00:03:03.041Zhttps://insights.citeline.com/companies/enleofen-bio-pte-ltd2026-04-07T00:02:56.868Zalways0.5Insightsen2026-04-07T00:02:56.868Zhttps://insights.citeline.com/companies/cocrystal-pharma-inc2026-04-07T00:02:50.982Zalways0.5Insightsen2026-04-07T00:02:50.982Zhttps://insights.citeline.com/companies/pfizer-inc2026-04-07T00:02:41.806Zalways0.5Insightsen2026-04-07T00:02:41.806Zhttps://insights.citeline.com/companies/toyota-motor-corporation2026-04-07T00:02:29.748Zalways0.5Insightsen2026-04-07T00:02:29.748Zhttps://insights.citeline.com/companies/leidos-inc2026-04-07T00:02:18.312Zalways0.5Insightsen2026-04-07T00:02:18.312Zhttps://insights.citeline.com/companies/visufarma-bv2026-04-07T00:02:05.964Zalways0.5Insightsen2026-04-07T00:02:05.964Zhttps://insights.citeline.com/companies/dompe-farmaceutici-spa2026-04-07T00:01:53.743Zalways0.5Insightsen2026-04-07T00:01:53.743Zhttps://insights.citeline.com/companies/anaptysbio-inc2026-04-07T00:01:41.799Zalways0.5Insightsen2026-04-07T00:01:41.799Zhttps://insights.citeline.com/companies/advenchen-laboratories-llc2026-04-07T00:01:30.023Zalways0.5Insightsen2026-04-07T00:01:30.023Zhttps://insights.citeline.com/companies/biogen-inc2026-04-07T00:01:17.72Zalways0.5Insightsen2026-04-07T00:01:17.72Zhttps://insights.citeline.com/companies/merck-kgaa2026-04-07T00:00:53.769Zalways0.5Insightsen2026-04-07T00:00:53.769Z